The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
November 30th 2024
Findings from PsABIOnd can help reassure clinicians of similar efficacy between treatment choices.
November 27th 2024
November 26th 2024
November 25th 2024
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Medical Specialists Mount International Effort to Restore Critical Epilepsy Services in Haiti
The international community of epilepsy specialists is providing financial support and specialized medical equipment contributed by its manufacturer to help re-establish services to epilepsy patients in Haiti halted by the devastating earthquake.
Medical Marijuana: Smoke & Mirrors?
February 2nd 2010When our home state of New Jersey became the 14th state in the nation to legalize medical marijuana, OBTN decided to take a closer look at the herbal remedy. With help from oncologists on our advisory board, we sought to filter through the smoke and examine the realities of medical marijuana.
Osteoarthritis treatment update: Are NSAIDs still in the picture?
February 1st 2010Although NSAIDs are the most effective treatment for persons who experience the pain of osteoarthritis (OA), the risk of adverse effects with NSAIDs may outweigh the benefits in many older patients. The GI risk is well known; increased attention has been paid recently to the cardiovascular risk. The goals of OA management are pain reduction and improvement or preservation of mobility. A multidisciplinary approach to treatment is recommended.
Biomarker Could Help Doctors Tailor Treatment for Rheumatoid Arthritis
January 29th 2010TNF antagonists are not highly effective in 30 to 50 percent of patients, but investigators have discovered that patients with higher baseline levels of type I interferon beta were more likely to respond to therapy.
Do age and bone density alone predict fracture risk as well as FRAX?
January 29th 2010A simple model based on age and bone mineral density (BMD) alone may predict 10-year risk of hip, major osteoporotic, and any clinical fracture in older women as well as more complex fracture risk assessment tool (FRAX) models with BMD.
Use adult RA assessment tools for juvenile idiopathic arthritis?
January 29th 2010Continuous measures of disease activity used for assessment of adult rheumatoid arthritis may be valid measures in children with polyarticular-course juvenile idiopathic arthritis (JIA). The scores may be valid in larger cohorts of children with polyarticular-course JIA that include children with early JIA and with varying degrees of disease severity.
Autoantibodies put patients on watch list for cardiovascular disease
January 29th 2010Both systemic inflammation and immune dysregulation, including autoantibody production, may occur even in the absence of autoimmune rheumatologic diseases, such as rheumatoid arthritis and systemic lupus erythematosus.
Lupus an independent risk factor for coronary artery disease
January 28th 2010Women with systemic lupus erythematosus (SLE) are at increased risk for coronary artery disease (CAD) and mortality. The dominant risk factors are SLE itself, age, and high total triglyceride levels rather than the traditional Framingham risk factors.
New Ways to Use Social Networking Sites
USA Today has published an interesting opinion piece by Kevin Pho, MD, encouraging physicians to embrace social networking tools as a way to interact with patients. For me, the comments on the article were as interesting as the article itself.
Apple's iPad an Impressive Product in Need of Tweaking for Healthcare Success
January 28th 2010Apple's iPad is sleek, innovative, and should change the landscape of the tablet computer market going forward. But for all the things they got right, Apple has a few things to learn if it wants to become the the healthcare industry's tablet leader.
Psoriasis more severe, with more psychological effects, in minorities
January 28th 2010Psychological effects resulting from psoriasis and psoriatic arthritis (PsA) are more likely to occur in African Americans, Asians, and Latinos than in whites, according to a recent National Psoriasis Foundation (NPF) survey report. In addition, very severe disease is more common among members of these groups.